Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The coagulopathy of chronic liver disease.

Literature DB >> 21751907

The coagulopathy of chronic liver disease.

Armando Tripodi¹, Pier Mannuccio Mannucci.

Abstract

Entities: Disease

Mesh：

Year: 2011 PMID： 21751907 DOI： 10.1056/NEJMra1011170

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

264 in total

Review 1. Reducing transfusion requirements in liver transplantation.

Authors: Ciara I Donohue; Susan V Mallett
Journal: World J Transplant Date: 2015-12-24

2. Blood investigations prior to oral surgery for suspected alcohol-induced coagulopathy. Are they necessary?

Authors: S Quach; A E Brooke; A Clark; S J Ellison
Journal: Br Dent J Date: 2015-08-14 Impact factor: 1.626

3. Population Pharmacokinetics and Pharmacodynamics of Apixaban Linking Its Plasma Concentration to Intrinsic Activated Coagulation Factor X Activity in Japanese Patients with Atrial Fibrillation.

Authors: Satoshi Ueshima; Daiki Hira; Chiho Tomitsuka; Miki Nomura; Yuuma Kimura; Takuya Yamane; Yohei Tabuchi; Tomoya Ozawa; Hideki Itoh; Minoru Horie; Tomohiro Terada; Toshiya Katsura
Journal: AAPS J Date: 2019-06-24 Impact factor: 4.009

Review 4. [Coagulation management in patients with liver disease].

Authors: A Bienholz; A Canbay; F H Saner
Journal: Med Klin Intensivmed Notfmed Date: 2015-05-05 Impact factor: 0.840

Review 5. Anticoagulant therapy with the oral direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban and the thrombin inhibitor dabigatran etexilate in patients with hepatic impairment.

Authors: Jochen Graff; Sebastian Harder
Journal: Clin Pharmacokinet Date: 2013-04 Impact factor: 6.447

The coagulopathy of chronic liver disease.

Review 1. Reducing transfusion requirements in liver transplantation.

2. Blood investigations prior to oral surgery for suspected alcohol-induced coagulopathy. Are they necessary?

3. Population Pharmacokinetics and Pharmacodynamics of Apixaban Linking Its Plasma Concentration to Intrinsic Activated Coagulation Factor X Activity in Japanese Patients with Atrial Fibrillation.

Review 4. [Coagulation management in patients with liver disease].

Review 5. Anticoagulant therapy with the oral direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban and the thrombin inhibitor dabigatran etexilate in patients with hepatic impairment.

6. Discharge Disposition After Stroke in Patients With Liver Disease.

7. Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats.

Review 8. Venous thromboembolism in cirrhosis: a review of the literature.

Review 9. Perioperative management of the bleeding patient.

Review 10. Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.